Adaptive platform trials after the COVID-19 pandemic
Lennie DERDE(Netherlands), Chris C. BUTLER (United Kingdom), Marius TROSEID (Norway), Steven TONG (Australia), Marlieke DE KRAKER (Switzerland)
Wednesday, 17 April 2023 |  |
Clinical trial platforms for new and neglected antimicrobials
J. Rodríguez-Baño (Seville, Spain), Julia Bielicki (Basel, Switzerland), Marc Bonten(Utrecht, the Netherlands))
Wednesday, 20 September 2023 | |
European Clinical Research Alliance on Infectious Diseases (ecraid)
M. De Craker (Geneva, Switzerland)
Sunday, 16 April 2023 | |
Diagnosis of bloodstream infection: between tradition and innovation
Giulia DE ANGELIS (Italy, Flora Marzia LIOTTI (Italy), Giulia MENCHINELLI (Italy), Ivana PALUCCI (Italy), Maurizio SANGUINETTI (Italy)
Wednesday, 23 February 2022 | |
How to make clinical trials more efficient
M. Bonten (Utrecht, Netherlands), H. Goossens (Antwerp, Belgium), M. Zarrouk (Köln, Germany), Marlieke de Kraker (Geneva, Switzerland), C. H. van Werkhoven (Utrecht, Netherlands)
Sunday, 24 April 2022 | |